Discovery of 2-Amide-3-methylester Thiophenes that Target SARS-CoV-2 Mac1 and Repress Coronavirus Replication, Validating Mac1 as an Antiviral Target
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.3c02451 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Sarah Wazir und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biochemistry and Molecular Medicine & Biocenter Oulu, University of Oulu, 90220 Oulu, Finland. Hauptthemen laut MEDLINE: Antiviral Agents, Thiophenes, Virus Replication, SARS-CoV-2. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCATS NIH HHS, U.S. Department of Health and Human Services.
Abstract (Originalsprache)
The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has made it clear that further development of antiviral therapies will be needed. Here, we describe small-molecule inhibitors for SARS-CoV-2 Mac1, which counters ADP-ribosylation-mediated innate immune responses. Three high-throughput screening hits had the same 2-amide-3-methylester thiophene scaffold. We studied the compound binding mode using X-ray crystallography, allowing us to design analogues. Compound 27 (MDOLL-0229) had an IC50 of 2.1 μM and was selective for CoV Mac1 proteins after profiling for activity against a panel of viral and human proteins. The improved potency allowed testing of its effect on virus replication, and indeed, 27 inhibited replication of both murine hepatitis virus (MHV) prototypes CoV and SARS-CoV-2. Sequencing of a drug-resistant MHV identified mutations in Mac1, further demonstrating the specificity of 27. Compound 27 is the first Mac1-targeted small molecule demonstrated to inhibit coronavirus replication in a cell model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Biochemistry and Molecular Medicine & Biocenter Oulu, University of Oulu, 90220 Oulu, Finland.
- Research Unit of Sustainable Chemistry, University of Oulu, P.O. Box 4300, 90014 Oulu, Finland.
- Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas 66045, United States.
- McDaniel College Department of Chemistry, 2 College Hill, Westminster, Maryland 21157, United States.
ORCID-Profile: Tomi A O Parviainen, Dana Ferraris, Juha P Heiskanen, Lari Lehtiö
Förderung
- NIGMS NIH HHS
- NCATS NIH HHS
- U.S. Department of Health and Human Services
- Emil Aaltosen S????ti??
- Sigrid Jus??liuksen S????ti??
- Oulun Yliopisto
Zitieren
APA
Wazir, S., Parviainen, T. A. O., Pfannenstiel, J. J., Duong, M. T. H., Cluff, D., Sowa, S. T., Galera-Prat, A., Ferraris, D., Maksimainen, M. M., Fehr, A. R., Heiskanen, J. P., & Lehtiö, L. (2024). Discovery of 2-Amide-3-methylester Thiophenes that Target SARS-CoV-2 Mac1 and Repress Coronavirus Replication, Validating Mac1 as an Antiviral Target. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c02451
Vancouver
Wazir S, Parviainen TAO, Pfannenstiel JJ, Duong MTH, Cluff D, Sowa ST, et al. Discovery of 2-Amide-3-methylester Thiophenes that Target SARS-CoV-2 Mac1 and Repress Coronavirus Replication, Validating Mac1 as an Antiviral Target. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.3c02451
BibTeX
@article{Wazir2024,
author = {Wazir, Sarah and Parviainen, Tomi A O and Pfannenstiel, Jessica J and Duong, Men Thi Hoai and Cluff, Daniel and Sowa, Sven T and Galera-Prat, Albert and Ferraris, Dana and Maksimainen, Mirko M and Fehr, Anthony R and Heiskanen, Juha P and Lehtiö, Lari},
title = {Discovery of 2-Amide-3-methylester Thiophenes that Target SARS-CoV-2 Mac1 and Repress Coronavirus Replication, Validating Mac1 as an Antiviral Target},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.3c02451}
}
EUVIMED